Unique ID issued by UMIN | UMIN000046679 |
---|---|
Receipt number | R000053226 |
Scientific Title | Preliminary Study of Cognitive-Behavior Group Therapy for Depressive Disorders and Anxiety Disorders |
Date of disclosure of the study information | 2022/01/20 |
Last modified on | 2022/09/05 10:16:20 |
Preliminary Study of Cognitive-Behavior Group Therapy for Depressive Disorders and Anxiety Disorders
CogGr study
Preliminary Study of Cognitive-Behavior Group Therapy for Depressive Disorders and Anxiety Disorders
CogGr study
Japan |
Depressive Disorder
Anxiety Disorder
Psychiatry |
Others
NO
The purpose of this study is to evaluate the feasibility and safety of Cognitive-Behavior Group Therapy for depressive disorders and anxiety disorders.
Safety
Not applicable
Dropout rate based on the following points;
1. Voluntary discontinuation at the request of the patient
2. Discontinuation due to symptom deterioration according to clinical findings
3. Discontinuation due to absence of 3 or more sessions out of total 8 sessions
The validity of the judgement of dropout will be determined by the Efficacy and Safety Evaluation Committee.
Pre and post intervention assessment
-Coping stress: CISS (Coping Inventory for Stressful Situation)
-Depressive symptom: PHQ-9 (Patient Health Questionnaire-9)
-Anxiety symptom: GAD-7 (Generalized Anxiety Disorder)
-QOL: EQ5D-5L (European Quality of Life Questionnaire-5 Dimension)
-Disability: SDISS (Sheehan Disability Scale)
-Satisfaction: CSQ-8 (Client Satisfaction G)
-Others: Questionnaire on the use of CBT skill after participating in CBGT
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom |
Cognitive-Behavior Group Therapy
20 | years-old | <= |
70 | years-old | >= |
Male and Female
1. Subjects with DSM-V Depressive Disorder or Anxiety Disorder
2. Subjects with CGIS (Clinical Global Impression) score is 3(mildly ill), 4(Moderately ill) or 5(Markedly ill).
3. Subjects between the ages of 20 and 70 at the time of screening
4. Subjects can obtain written consent
1. No alcohol or substance use disorder in 24 months prior to the screening.
2. No history or concurrent manic, psychotic episode.
3. No other primary Axis I Disorders in 6 months prior to the screening.
4. No comorbid of antisocial personality disorder.
5. No serious suicidal ideation at screening.
6. Unlikely to attend more than 4 visits during the 8-week trial phase.
7. No treatment of CBT or CBGT within the last year prior to the screening.
8. No organic brain lesions or major cognitive deficits.
9. No severe or unstable medical illness at screening.
10. Other relevant reason decided by the CogGr principal investigator.
10
1st name | Toshiaki |
Middle name | |
Last name | Kikuchi |
Keio University, School of Medicine
Department of Neuropsychiatry
160-8582
35 Shinanomachi Shinjuku-ku, Tokyo
03-5363-3829
kikuchi.psychiatry@gmail.com
1st name | Miyuki |
Middle name | |
Last name | Tajima |
Keio University, School of Medicine
Department of Neuropsychiatry
160-8582
35 Shinanomachi Shinjuku-ku, Tokyo
03-5363-3829
taji0808@gmail.com
Keio University, School of Medicine
Grant-in-Aid for Scientific Research
Japanese Governmental office
Research Ethics Committee of Keio University, School of Medicine
35 Shinanomachi Shinjuku-ku, Tokyo
03-3353-1211 (ex. 62014)
med-rinri-jimu@adst.keio.ac.jp
NO
慶應義塾大学医学部/慶應義塾大学病院(東京都)
2022 | Year | 01 | Month | 20 | Day |
Unpublished
Completed
2022 | Year | 01 | Month | 20 | Day |
2022 | Year | 01 | Month | 11 | Day |
2022 | Year | 02 | Month | 10 | Day |
2023 | Year | 03 | Month | 31 | Day |
2022 | Year | 01 | Month | 20 | Day |
2022 | Year | 09 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053226